Watch Ticker

Achieve Life Sciences, Inc.

Go to Achieve Life Sciences, Inc. Website

$5.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$171.7 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been app...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Achieve Life Sciences - Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced data from the Phase 2 ORCA-V1 vaping cessation trial will be presented today, Friday, May 17, 2024, at the Society of General Internal Medicine (SGIM) Annual Meeting being held in Boston, MA.

Related tickers: ACHV.

Read Full Article

Achieve Life Sciences - Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Company to host conference call at 4:30 PM EDT today, Thursday, May 9, 2024 Company to host conference call at 4:30 PM EDT today, Thursday, May 9, 2024

Related tickers: ACHV.

Read Full Article

Trending Tickers

FLGC

XNAS

$1.31

(%)

IBIT

XNAS

$38.28

(%)

LASE

XNAS

$2.16

(%)

MGAM

XNAS

$0.02

(%)

MLGO

XNAS

$0.00

(%)